MX2009008813A - Composicion farmaceutica que contiene floroglucinol y paracetamol. - Google Patents

Composicion farmaceutica que contiene floroglucinol y paracetamol.

Info

Publication number
MX2009008813A
MX2009008813A MX2009008813A MX2009008813A MX2009008813A MX 2009008813 A MX2009008813 A MX 2009008813A MX 2009008813 A MX2009008813 A MX 2009008813A MX 2009008813 A MX2009008813 A MX 2009008813A MX 2009008813 A MX2009008813 A MX 2009008813A
Authority
MX
Mexico
Prior art keywords
paracetamol
pharmaceutical composition
composition containing
containing phloroglucinol
phloroglucinol
Prior art date
Application number
MX2009008813A
Other languages
English (en)
Inventor
Jean-Jacques Serrano
Claudette Serrano
Original Assignee
Promindus Actions Promotionnel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promindus Actions Promotionnel filed Critical Promindus Actions Promotionnel
Publication of MX2009008813A publication Critical patent/MX2009008813A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a una composición farmacéutica para administración por vía oral o rectal, que contiene floroglucinol y paracetamol en un portador farmacéuticamente aceptable. Los inventores han puesto en evidencia una sinergia desarrollada por esos dos ingredientes activos en terapia antiespasmódica.
MX2009008813A 2007-02-19 2008-02-18 Composicion farmaceutica que contiene floroglucinol y paracetamol. MX2009008813A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0753351A FR2912654B1 (fr) 2007-02-19 2007-02-19 Association medicamenteuse comprenant du phloroglucinol et du paracetamol
PCT/FR2008/050263 WO2008113929A1 (fr) 2007-02-19 2008-02-18 Composition pharmaceutique renfermant du phloroglucinol et du paracetamol

Publications (1)

Publication Number Publication Date
MX2009008813A true MX2009008813A (es) 2010-03-03

Family

ID=38581909

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008813A MX2009008813A (es) 2007-02-19 2008-02-18 Composicion farmaceutica que contiene floroglucinol y paracetamol.

Country Status (9)

Country Link
US (1) US8148425B2 (es)
EP (1) EP2120901A1 (es)
BR (1) BRPI0810057A2 (es)
CA (1) CA2678042C (es)
FR (1) FR2912654B1 (es)
MA (1) MA31227B1 (es)
MX (1) MX2009008813A (es)
WO (1) WO2008113929A1 (es)
ZA (1) ZA200905440B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940911B1 (fr) * 2009-01-13 2012-09-21 Philippe Perovitch Formulation pour l'administration par voie trans-muqueuse buccale de molecules antalgiques et/ou anti-spasmodiques
IT1396649B1 (it) * 2009-12-04 2012-12-14 Diverdrugs Sl Preparazioni farmaceutiche comprendenti floroglucinolo e/o suoi derivati e farmaci anti-infiammatori non steroidi e loro uso nel trattamento e/o nella prevenzione delle sindromi dolorose dell'apparato genitale femminile.
FR2984165B1 (fr) * 2011-12-16 2014-06-27 Pharmeuro Traitement des crises de migraines, notamment d'algies vasculaires de la face
FR3060391A1 (fr) * 2016-12-20 2018-06-22 Promindus Sarl Composition pharmaceutique anti douleur

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528310B2 (en) * 1978-11-16 1983-04-21 Beecham Group Plc Composition of paracetamol and metoclopramide
FR2735025B1 (fr) * 1995-06-12 1997-08-22 Fabre Pierre Sante Composition therapeutique contenant une association d'ibuprofene et de phloroglucinol et son utilisation comme antispasmodique
EP0805679A1 (fr) * 1995-11-28 1997-11-12 Christophe Boyer Utilisation therapeutique d'agents betamimetiques pour traiter les douleurs menstruelles par voie permuqueuse
FR2793685B1 (fr) * 1999-05-19 2001-08-24 Promindus Actions Promotionnel Compositions pharmaceutiques, destinees a l'administration par voie orale de phloroglucinol et leur preparation
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
US6716884B1 (en) * 2000-05-19 2004-04-06 Promindus (Actions Promotionnelles Dans L'industrie Et Le Commerce) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof

Also Published As

Publication number Publication date
ZA200905440B (en) 2010-10-27
FR2912654A1 (fr) 2008-08-22
US20100168238A1 (en) 2010-07-01
CA2678042C (fr) 2016-05-31
BRPI0810057A2 (pt) 2014-10-21
FR2912654B1 (fr) 2009-12-25
MA31227B1 (fr) 2010-03-01
CA2678042A1 (fr) 2008-09-25
US8148425B2 (en) 2012-04-03
EP2120901A1 (fr) 2009-11-25
WO2008113929A1 (fr) 2008-09-25

Similar Documents

Publication Publication Date Title
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
MX2009010289A (es) Composiciones para administracion nasal.
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
UA105210C2 (ru) Противораковая вакцина и ее применение
MX2020011961A (es) Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
MX2009013501A (es) Compuestos piperidinicos y sus usos.
MY177027A (en) Novel dosage and formulation
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
MX2021004883A (es) Metodos y composiciones para tratar apnea del sue?o.
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
GB0615105D0 (en) Novel compounds
GEP20115158B (en) Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.
TW200633717A (en) Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
GB0620619D0 (en) Novel compounds
MX2009009178A (es) Bis-fosforatos de bazedoxifeno.
WO2010022277A3 (en) Combination of 10-propargyl-10-deazaaminopterin and bortezomib for the treatment of cancers
TNSN08442A1 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
UA93755C2 (uk) Засіб, що проявляє ноотропну активність, має антихолестеразну дію, відновлює та стимулює нервово-м`язову передачу
MY150646A (en) Modified release formulations of a bupropion salt
UA93515C2 (ru) Медикаментозное средство ha ochobe рутина

Legal Events

Date Code Title Description
FG Grant or registration